Abstract:ObjectivesPulmonary arterial hypertension (PAH) is a severe complication of connective tissue disease (CTD) with a poor prognosis. There have been sporadic reports with respect to the clinical features and survival of CTD associated PAH (CPAH), however, those in Chinese with CPAH are unknown yet. The purpose of this study is to investigate the baseline characteristics, survival and risk factors of mortality in Chinese with CPAH.MethodsAll consecutive adult patients who visited the three medical centres with confirmed diagnosis of CPAH between July 2006 and May 2011 were enrolled into the study. For all these patients, PAH was confirmed by right heart catheterisation.ResultsA total of 144 patients (40.6±12.6 years old) were included in the study and 44% of them were associated with SLE. The other underlying CTDs, in the descending rank order, are pSS (15%), Takayasu arteritis (12%), MCTD (10%), SSc (8%) and some others (RA 3%, PM/DM 2%, adult onset Still9disease 2%, UCTD 2%, primary APS 1%, and ANCA associated vasculitis 1%). The median duration between symptom onset and diagnostic catheterisation was 16.5 months. At diagnosis, 57.6% of patients were in WHO functional class III/IV. The 6-min walk distance was 377.0±99.7 m. Mean pulmonary artery pressure was 49.7±14.4 mm Hg. Eighty-five percent of patients received vascular-targeted therapy. One hundred and twenty-nine patients were followed up with a median duration of 15.8 months (ranged 1.1–55.1 months). The survival rates of these patients at 1 and 3 years were 87.8% and 53.8%. The survival rates of patients with SLE associated PAH at 1 and 3 years were 90.0% and 57.1%. K-M survival analysis showed there were no significant differences in the survivals among different connective tissue diseases. Univariate Cox analysis showed shorter 6-min walk distance, lower cardiac output, cardiac index and mixed venous oxygen saturation, higher pulmonary vascular resistance (PVR), alkaline phosphatase (ALP), total bilirubin and direct bilirubin, lower total cholesterol and low-density lipoprotein were associated with high risk of death (all p<0.05). Multivariate Cox analysis showed higher PVR and ALP were independent predictors of mortality (HR were 1.32 (1.03–1.68) and 1.70 (1.01–2.87) respectively, both p<0.05). K-M analysis demonstrated the survival rate in PVR<15 wood unit group was higher significantly than that in ≥15 wood unit group (p=0.009), and the survival rate in ALp<150 U/l group higher than that in ≥150 U/l group (p=0.012).ConclusionsSLE was the most common underlying disease of CPAH in China; however, SSc-associated PAH was fewer in Chinese patients, which were much different from Caucasians. The survival of Chinese patients with CPAH at 1 and 3 years were 87.8% and 53.8%, which were similar with the data of Western countries. Furthermore, elevated PVR and ALP were independent risk factors of bad outcomes.

Clinical analysis of 110 pulmonary arterial hypertension patients with connective tissue disease

Clinical Analysis Connective Tissue Disease Related Pulmonary Arterial Hypertension

Clinical Signiifcance of Liver Function in Connective Tissue Disease-related Pulmonary Arterial Hypertension

The Clinical Analysis of Pulmonary Arterial Hypertension in Connective Tissue Disease

Characteristics Of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Retrospective Cohort Study

[Diagnostic Value of CT Pulmonary Artery Imaging for Idiopathic Pulmonary Artery Hypertension].

Clinical analysis of 305 patients with connective tissue disease associated interstitial lung disease

Clinical Characteristics and Factors Associated with Disease Progression in Chinese Patients with Connective Tissue Disease and Pulmonary Arterial Hypertension

Characteristics and Survival of Connective Tissue Disease Associated Pulmonary Arterial Hypertension Patients with and Without Interstitial Lung Disease

Early detection and treatment of connective tissue disease associated pulmonary arterial hypertension

Clinical characteristics of systemic sclerosis-associated pulmonary arterial hypertension

Clinical characteristics and survival of patients with three major connective tissue diseases associated with pulmonary hypertension: A study from China

The role of immune cells in the pathogenesis of connective tissue diseases-associated pulmonary arterial hypertension

Clinical manifestations of connective tissue diseases complicated with interstitial lung disease:an analysis of 90 cases

Relationship Between Cardiac Damage and Pulmonary Hypertension in Patients with Connective Tissue Disease

The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease

Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension

Two distinct clinical phenotypes of pulmonary arterial hypertension secondary to systemic lupus erythematosus.

Baseline Characteristics And Survival Of Chinese Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients.

Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis